Syndax Pharmaceuticals Inc (NASDAQ:SNDX) currently has 43 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30 Sep, 2025 | 8,625,244 | -1,831,663 | -17.52% | $132,699,393.00 |
| Kynam Capital Management, LP | 30 Sep, 2025 | 8,520,000 | 0 | 0.00% | $131,080,200.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 5,486,434 | -310,761 | -5.36% | $84,408,787.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 5,138,617 | 104,683 | 2.08% | $79,057,621.00 |
| Point72 Asset Management, L.P. | 30 Sep, 2025 | 4,255,047 | 2,127,580 | 100.01% | $65,463,921.00 |
| STATE STREET CORP | 30 Sep, 2025 | 3,853,549 | 410,797 | 11.93% | $59,286,852.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 3,697,753 | -141,119 | -3.68% | $56,889,929.00 |
| Eversept Partners, LP | 30 Sep, 2025 | 3,467,314 | -598,041 | -14.71% | $53,344,626.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 3,311,963 | 1,879,523 | 131.21% | $50,954,551.00 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 30 Sep, 2025 | 2,500,000 | 400,000 | 19.05% | $38,462,500.00 |
| FRANKLIN RESOURCES INC | 30 Sep, 2025 | 2,390,561 | 30,884 | 1.31% | $36,778,786.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,091,331 | 41,981 | 2.05% | $32,179,868.00 |
| Soleus Capital Management, L.P. | 30 Sep, 2025 | 2,012,110 | 920,000 | 84.24% | $30,956,312.00 |
| Assenagon Asset Management S.A. | 30 Sep, 2025 | 1,784,139 | -255,848 | -12.54% | $27,448,979.00 |
| UBS Group AG | 30 Sep, 2025 | 1,674,513 | 239,098 | 16.66% | $25,762,382.00 |
| Qube Research & Technologies Ltd | 30 Sep, 2025 | 1,644,844 | -21,072 | -1.26% | $25,305,925.00 |
| Catalio Capital Management, LP | 30 Sep, 2025 | 1,614,717 | -489,795 | -23.27% | $24,842,421.00 |
| Woodline Partners LP | 30 Sep, 2025 | 1,550,520 | -342,231 | -18.08% | $23,854,750.00 |
| Nuveen, LLC | 30 Sep, 2025 | 1,475,798 | 1,209,755 | 454.72% | $22,705,153.00 |
| MPM BioImpact LLC | 30 Sep, 2025 | 1,375,674 | 1,375,674 | 0.00% | $21,164,744.00 |